Target intelligence / Profile preview

Vestigial like family member 2 (VGLL2)

Target
VGLL2
Molecular classification
Transcription cofactor, Transcription regulator, Vestigial-like family protein
01

Overview

Vestigial like family member 2 (VGLL2) is a transcription cofactor belonging to the vestigial-like family, primarily expressed in skeletal muscle and critical for muscle cell differentiation and maintenance of muscle fiber identity. VGLL2 interacts with key transcription factors such as TEF/TEAD and MEF2 to co-regulate the expression of muscle-specific genes and modulate the programing of slow-contractile muscle fibers. VGLL2 is essential in embryonic skeletal muscle development, as well as in adult muscle adaptation to chronic overload, by shifting muscle metabolism and contractile properties toward a slower phenotype. Genomic rearrangements involving VGLL2 can act as oncogenic drivers in congenital and infantile spindle cell rhabdomyosarcoma, forming fusion proteins (notably VGLL2–CITED2 and VGLL2–NCOA2) that may serve as distinct molecular markers or diagnostic features in pediatric sarcomas. There are currently no drugs specifically directed at VGLL2, nor is it an established therapeutic target.

Other names
Transcription cofactor vestigial-like protein 2VITO1Vgl-2Protein VITO1VGL2vestigial like 2Vestigial and Tondu related protein 1
02

Biological functions

Regulation of skeletal muscle differentiation and developmentCoactivation of TEF/TEAD transcription factorsControl of muscle fiber-type composition and adaptation
03

Disease associations

Cancer (notably pediatric spindle cell/sclerosing rhabdomyosarcoma, often via gene fusion events)
04

Safety considerations

Safety concerns are not specifically documented as VGLL2 is not a pharmacological target; theoretical concerns could arise if considered for targeting due to its essential role in muscle differentiation and development

Beyond the preview

Go deeper on Vestigial like family member 2 (VGLL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vestigial like family member 2 (VGLL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call